Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04063709 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 8 months later Nov 2025 → Aug 2027
See other at-risk trials from University of North Carolina, Chapel Hill

Record History

  1. Primary and study completion pushed from Nov 2025 to Aug 2027 Final enrollment: 72 participants (planned 80)v7 Show 1 more changeShow less
    • Final enrollment: 72 participants (planned 80)
  2. Primary and study completion dates: Jul 16, 2024 to Nov 2025 Trial status: Recruiting to Active, Not Recruiting · Secondary endpoints: details revised at 54 of 54 entries · Site details revisedv6 Show 3 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Secondary endpoints: details revised at 54 of 54 entries
    • Site details revised
  3. Re-verified, no change to tracked fieldsv5
  4. Trial status: Suspended to Recruiting Primary completion date: Jul 16, 2023 to Jul 16, 2024 · Site details revisedv4 Show 2 more changesShow less
    • Primary completion date: Jul 16, 2023 to Jul 16, 2024
    • Site details revised
  5. Re-verified, no change to tracked fieldsv3
  6. Trial status: Recruiting to Suspended Sponsor's reason: Suspended due to COVID-19 risks Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stroke is a leading cause of death and disability in the United States and around the world. The goal of this work is to develop and test a noninvasive ultrasound-based imaging technology to better identify patients at high risk of stroke so that appropriate and timely intervention may be administered to prevent it.
Trial Details
NCT Number NCT04063709
Lead Sponsor University of North Carolina, Chapel Hill
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Plaque, Atherosclerotic, Carotid Artery Plaque, Carotid Stenosis
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov